US Stock MarketDetailed Quotes

MRES INSTITUTE BIOMEDICAL RESH CORP

Watchlist
  • 0.017
  • 0.000-0.29%
15min DelayTrading Dec 26 09:30 ET
40.78MMarket Cap-0.02P/E (TTM)

INSTITUTE BIOMEDICAL RESH CORP Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2010
(Q2)Sep 30, 2010
(Q1)Jun 30, 2010
(FY)Mar 31, 2010
(Q4)Mar 31, 2010
(Q3)Dec 31, 2009
(Q2)Sep 30, 2009
(Q1)Jun 30, 2009
(FY)Mar 31, 2009
(Q4)Mar 31, 2009
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
94.71%-5.18K
-38.58%-23.02K
-24.48%-31.28K
43.00%-231.77K
34.45%-92.11K
-18.87%-97.92K
80.34%-16.61K
74.68%-25.13K
-313.83%-406.62K
-124.28%-140.52K
Net income from continuing operations
45.42%-55.69K
-263.10%-76.92K
-158,371.31%-50.08M
38.32%-273.4K
20.95%-118.58K
-11.50%-102.03K
77.71%-21.18K
70.39%-31.6K
91.74%-443.29K
5.88%-150.02K
Depreciation and amortization
126.93%12.93K
155.49%12.93K
1,020,660.25%51.67M
-19.41%22.58K
33.04%6.75K
-26.23%5.7K
-34.50%5.06K
-32.37%5.06K
148.29%28.01K
-43.86%5.08K
Other non cash items
--0
--0
---1.63M
-58.71%2.34K
----
----
----
----
-99.83%5.66K
----
Change In working capital
2,469.10%37.57K
8,425.41%40.96K
678.78%11.01K
457.30%16.72K
1,499.60%17.38K
-212.16%-1.59K
-117.40%-492
--1.41K
109.50%3K
-139.99%-1.24K
-Change in receivables
--0
----
----
----
----
--3.75K
----
----
----
----
-Change in prepaid assets
----
----
--0
----
----
----
----
--1.41K
----
----
-Change in payables and accrued expense
804.16%37.57K
1,653.47%40.96K
--11.01K
457.30%16.72K
557.30%19.72K
---5.34K
--2.34K
--0
112.00%3K
--3K
Cash from discontinued investing activities
Operating cash flow
94.71%-5.18K
-38.58%-23.02K
-24.48%-31.28K
43.00%-231.77K
34.45%-92.11K
-18.87%-97.92K
80.34%-16.61K
74.68%-25.13K
-313.83%-406.62K
-124.28%-140.52K
Investing cash flow
Cash flow from continuing investing activities
0
-223.92%-23.66K
-8.46K
0
93.19%-7.3K
0
Net PPE purchase and sale
----
----
----
-2.70%-7.5K
205.41%7.7K
----
----
----
93.19%-7.3K
75.57%-7.3K
Net other investing changes
----
----
----
---16.16K
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--0
-223.92%-23.66K
---8.46K
----
----
--0
93.19%-7.3K
--0
Financing cash flow
Cash flow from continuing financing activities
-95.42%5.18K
38.58%23.02K
24.48%31.28K
-38.29%255.43K
-28.43%100.57K
37.32%113.12K
-80.34%16.61K
-76.41%25.13K
101.40%413.92K
125.60%140.52K
Net issuance payments of debt
-95.42%5.18K
38.58%23.02K
24.48%31.28K
----
----
--113.12K
--16.61K
--25.13K
----
----
Net common stock issuance
----
----
----
----
----
----
----
----
59.19%17.31K
----
Net other financing activities
----
----
----
-35.60%255.43K
----
----
----
----
103.75%396.61K
122.25%123.22K
Cash from discontinued financing activities
Financing cash flow
-95.42%5.18K
38.58%23.02K
24.48%31.28K
-38.29%255.43K
-28.43%100.57K
37.32%113.12K
-80.34%16.61K
-76.41%25.13K
101.40%413.92K
125.60%140.52K
Net cash flow
Beginning cash position
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
End cash Position
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Free cash flow
95.42%-5.18K
-38.58%-23.02K
-24.48%-31.28K
42.19%-239.27K
39.93%-84.41K
-37.32%-113.12K
80.34%-16.61K
76.41%-25.13K
-101.40%-413.92K
-125.60%-140.52K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Dec 31, 2010(Q2)Sep 30, 2010(Q1)Jun 30, 2010(FY)Mar 31, 2010(Q4)Mar 31, 2010(Q3)Dec 31, 2009(Q2)Sep 30, 2009(Q1)Jun 30, 2009(FY)Mar 31, 2009(Q4)Mar 31, 2009
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 94.71%-5.18K-38.58%-23.02K-24.48%-31.28K43.00%-231.77K34.45%-92.11K-18.87%-97.92K80.34%-16.61K74.68%-25.13K-313.83%-406.62K-124.28%-140.52K
Net income from continuing operations 45.42%-55.69K-263.10%-76.92K-158,371.31%-50.08M38.32%-273.4K20.95%-118.58K-11.50%-102.03K77.71%-21.18K70.39%-31.6K91.74%-443.29K5.88%-150.02K
Depreciation and amortization 126.93%12.93K155.49%12.93K1,020,660.25%51.67M-19.41%22.58K33.04%6.75K-26.23%5.7K-34.50%5.06K-32.37%5.06K148.29%28.01K-43.86%5.08K
Other non cash items --0--0---1.63M-58.71%2.34K-----------------99.83%5.66K----
Change In working capital 2,469.10%37.57K8,425.41%40.96K678.78%11.01K457.30%16.72K1,499.60%17.38K-212.16%-1.59K-117.40%-492--1.41K109.50%3K-139.99%-1.24K
-Change in receivables --0------------------3.75K----------------
-Change in prepaid assets ----------0------------------1.41K--------
-Change in payables and accrued expense 804.16%37.57K1,653.47%40.96K--11.01K457.30%16.72K557.30%19.72K---5.34K--2.34K--0112.00%3K--3K
Cash from discontinued investing activities
Operating cash flow 94.71%-5.18K-38.58%-23.02K-24.48%-31.28K43.00%-231.77K34.45%-92.11K-18.87%-97.92K80.34%-16.61K74.68%-25.13K-313.83%-406.62K-124.28%-140.52K
Investing cash flow
Cash flow from continuing investing activities 0-223.92%-23.66K-8.46K093.19%-7.3K0
Net PPE purchase and sale -------------2.70%-7.5K205.41%7.7K------------93.19%-7.3K75.57%-7.3K
Net other investing changes ---------------16.16K------------------------
Cash from discontinued investing activities
Investing cash flow ----------0-223.92%-23.66K---8.46K----------093.19%-7.3K--0
Financing cash flow
Cash flow from continuing financing activities -95.42%5.18K38.58%23.02K24.48%31.28K-38.29%255.43K-28.43%100.57K37.32%113.12K-80.34%16.61K-76.41%25.13K101.40%413.92K125.60%140.52K
Net issuance payments of debt -95.42%5.18K38.58%23.02K24.48%31.28K----------113.12K--16.61K--25.13K--------
Net common stock issuance --------------------------------59.19%17.31K----
Net other financing activities -------------35.60%255.43K----------------103.75%396.61K122.25%123.22K
Cash from discontinued financing activities
Financing cash flow -95.42%5.18K38.58%23.02K24.48%31.28K-38.29%255.43K-28.43%100.57K37.32%113.12K-80.34%16.61K-76.41%25.13K101.40%413.92K125.60%140.52K
Net cash flow
Beginning cash position --0--0--0--0--0--0--0--0--0--0
End cash Position --0--0--0--0--0--0--0--0--0--0
Free cash flow 95.42%-5.18K-38.58%-23.02K-24.48%-31.28K42.19%-239.27K39.93%-84.41K-37.32%-113.12K80.34%-16.61K76.41%-25.13K-101.40%-413.92K-125.60%-140.52K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.